Skip to main content
Springer logoLink to Springer
. 2020 Jun 22;24(4):505. doi: 10.1007/s40291-020-00479-2

Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

Valerie Pestinger 1, Matthew Smith 2, Toju Sillo 1, John M Findlay 3, Jean‑Francois Laes 4, Gerald Martin 5, Gary Middleton 6, Phillipe Taniere 2, Andrew D Beggs 1,2,
PMCID: PMC7363732  PMID: 32572786

Correction to: Molecular Diagnosis & Therapy (2020) 24:339–349 10.1007/s40291-020-00462-x

This article was originally published under a [CC BY NC 4.0] license, but has now been made available under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The PDF and HTML versions of the paper have been modified accordingly.


Articles from Molecular Diagnosis & Therapy are provided here courtesy of Springer

RESOURCES